Accueil » Communiqués de presse » Valbiotis announces positive results in the bioavailability and mode of action TOTUM•854 clinical study, against high blood pressure.
Les communiqués de presse
30Jan2023
Valbiotis announces positive results in the bioavailability and mode of action TOTUM•854 clinical study, against high blood pressure.
